Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

about

Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity

P2860

Q57070391-87877DC2-3568-4FC8-BA27-7434F7A2D4CD

P2860

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

Item

http://www.wikidata.org/entity/Q49805176

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Development and Characterizati ...... Active Doxorubicin Derivative.

@en

Development and Characterizati ...... Active Doxorubicin Derivative.

@nl

type

Item

label

Development and Characterizati ...... Active Doxorubicin Derivative.

@en

Development and Characterizati ...... Active Doxorubicin Derivative.

@nl

prefLabel

Development and Characterizati ...... Active Doxorubicin Derivative.

@en

Development and Characterizati ...... Active Doxorubicin Derivative.

@nl

P1476

Development and Characterizati ...... Active Doxorubicin Derivative.

@en

P2093

Chiara Dianzani

http://www.w3.org/2001/XMLSchema#string

Elena Peira

http://www.w3.org/2001/XMLSchema#string

Marina Gallarate

http://www.w3.org/2001/XMLSchema#string

Umberto Dianzani

http://www.w3.org/2001/XMLSchema#string

P2860

Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

The production and characteristics of solid lipid nanoparticles (SLNs).

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.

Anthracycline cardiotoxicity: from bench to bedside.

Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.

New strategies to deliver anticancer drugs to brain tumors.

Flow cytometry-based apoptosis detection

P31

scholarly article

P356

10.3390/NANO8020110

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Stella

Casimiro Luca Gigliotti

Elena Boggio

Franco Dosio

Luigi Battaglia

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29462932

http://www.w3.org/2001/XMLSchema#string

P932

5853741

http://www.w3.org/2001/XMLSchema#string

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

about

P2860

P2860

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932